TON - October 2010, Vol. 3, No 7

CHICAGO—Among patients with lung cancer on highly emetogenic chemotherapy, those receiving palonosetron throughout all cycles of chemotherapy had a 31% lower risk of chemotherapy-induced nausea and vomiting (CINV) associated with an emergency department or hospital visit, than patients receiving other 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists (RAs).

The study was presented by Hind T. Hatoum, PhD, of the Center of Pharmacoeconomic Research at the University of Illinois at Chicago during the 46th annual meeting of the American Society of Clinical Oncology.

Read More ›

The Doctor of Nursing Practice (DNP) degree has been designated by the American Association of Colleges of Nursing (AACN) as the graduate degree for advanced practice nurses (APNs). Currently, obtaining this degree remains an option; pursuit of a doctoral degree in nursing is a personal and professional decision made by some APNs. The trend toward doctoral preparation appears to be gaining momentum, however, and after the year 2015 it may be difficult to find a nurse practitioner program that awards a Master of Science in Nursing (MSN).

Read More ›

SEATTLE—New doctors have received on-the-job training in residency programs for decades. Now, a growing number of new nurses are doing the exact same thing. Nurse residency programs are now rising in popularity and that, in part, is due to hospitals trying to stave off a huge projected nursing shortage over the next 10 to 15 years.

Read More ›

CHICAGO—Targeted intraoperative radiotherapy (TIR) for breast cancer, in which radiotherapy is confined to the area of the breast where the tumor has been removed, has been found to be as good as whole breast radiotherapy at reducing breast cancer recurrence. Most important, the new data presented at the 46th annual meeting of the American Society of Clinical Oncology showed TIR can be carried out in just one hospital visit.

Read More ›

More than 400 navigators came together for 2 days of education, networking, and professional development, all with the goal of improving oncology patient care and quality of life. At its First Annual Navigation and Survivorship Conference, the Academy of Oncology Nurse Navigators (AONN) welcomed all team members involved in these crucial aspects of patient care—nurses, social workers, lay navigators, navigation and survivorship program administrators—from throughout the country and around the world.

Read More ›

St. Luke’s Mountain States Tumor Institute (MSTI) provides advanced cancer care to patients at clinics in Boise, Fruitland, Meridian, Nampa, and Twin Falls, Idaho. Spanning more than 180 miles across southwestern Idaho, MSTI cares for patients from rural areas and from metropolitan areas. Because of geographic isolation, many people in rural areas present at later stages of disease. In addition, large Hispanic populations in the rural counties of the state are not getting screened for cancers on recommended timelines.

Read More ›

As early as 3000 BC, descriptions can be found on Egyptian papyruses documenting reconstructive techniques used by priest doctors to restore altered appearances to normality. The upper echelons of Egyptian society placed great importance on appearance, and this seems to have been the stimulus for development of modern-day plastic surgery. Read More ›


After coping with the initial shock of a cancer diagnosis, many women decide to take a proactive approach and seek sound information and advice so that they can make informed decisions about their healthcare. The Oncology Nurse recently spoke with two young women who found that support groups were a valuable resource for obtaining information and forming bonds with other patients and survivors. One went on to create her own group to help women with specific needs she felt were not being met based on her own experience.

Read More ›

Cytotoxic chemotherapy is one of the cornerstones for the treatment of metastatic breast cancer (MBC). Read More ›


CHICAGO—Early initiation of palliative care (PC) in the management of metastatic non–small-cell lung cancer (NSCLC) led to a longer survival time and better quality of life (QOL) than standard treatment, in a randomized phase 3 trial.

The study compared QOL and clinical outcomes for early PC versus standard oncology care in 150 patients with newly diagnosed metastatic NSCLC. 

Read More ›

Page 1 of 2


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: